Drug Approval | November 16, 2025
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The EIR follows a product-specific Pre-Approval Inspection from September 1 to September 5, 2025.
A bio-analytical Remote Regulatory Assessment was also conducted from October 30 to November 7, 2025, and concluded with no observations
Cupid has been allocated approximately 23.4 million units of female condoms per year
AI-powered cardiometabolic wellness platform for India’s workforce
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
The product is indicated for the chronic management of patients with Urea Cycle Disorders
Subscribe To Our Newsletter & Stay Updated
